more details on vitiligo data analysis

Research evidence excerpt

more details on vitiligo data analysis

titutes an offer, invitation or request to purchase or subscribe for securities or other

instruments or to make or cancel investments, nor may it serve as the basis for any contract, commitment or decision of any kind.

For persons in the UK: In making this report available, Evercore makes no recommendation to buy, sell or otherwise deal in any securities or

investments whatsoever and you should neither rely or act upon, directly or indirectly, any of the information contained in this report in respect of

any such investment activity. This report is being directed at or distributed to, (a) persons who fall within the definition of Investment Professionals

(set out in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”)); (b) persons falling within

the definition of high net worth companies, unincorporated associations, etc. (set out in Article 49(2) of the Order); (c) other persons to whom it

may otherwise lawfully be communicated (all such persons together being referred to as “relevant persons”). This report must not be acted on or

relied on by persons who are not relevant persons.

For persons in Switzerland: The distribution of these materials to persons or entities in Switzerland is not intended to, and does not, constitute a

financial service under the Swiss Financial Services Act (FinSA). In particular, the distribution of these materials does not constitute the provision

of personal recommendations on transactions with financial instruments (investment advice) within the meaning of Article 3(c)(4) of FinSA.

For persons in Australia: Evercore does not have an Australian Financial Services License ("AFSL"). This report is only to be distributed to